Acadia Healthcare (NASDAQ:ACHC) Stock Price Down 4.9% – What’s Next?

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) shares traded down 4.9% on Monday . The company traded as low as $32.46 and last traded at $32.82. Approximately 362,969 shares traded hands during trading, a decline of 89% from the average session volume of 3,301,906 shares. The stock had previously closed at $34.51.

Key Acadia Healthcare News

Here are the key news stories impacting Acadia Healthcare this week:

• Positive Sentiment: Second-quarter adjusted earnings were $0.38 per share, above estimates of approximately $0.33-$0.35. Revenue of $865.8 million also exceeded the roughly $844.2 million consensus estimate. Acadia Healthcare Surpasses Q2 Earnings and Revenue Estimates
• Positive Sentiment: Management maintained fiscal 2026 revenue guidance of $3.4 billion-$3.5 billion and set EPS guidance at $1.45-$1.60, a range whose midpoint is slightly above the approximately $1.51 analyst consensus. The company also updated its full-year cash-flow outlook. Acadia Healthcare Announces Second Quarter Results and Updates Guidance
• Neutral Sentiment: Reported revenue was approximately flat from a year earlier at $865.8 million, although management said normalized growth was 2.8% after adjusting for prior-period supplemental-payment revenue. This indicates modest underlying growth but limited headline expansion. Acadia Healthcare Q2 Earnings Snapshot
• Negative Sentiment: Quarterly EPS fell from $0.83 to $0.38 year over year, and the company reported a negative net margin. The earnings beat therefore reflects performance above reduced expectations rather than year-over-year profit growth.
• Negative Sentiment: A federal court allowed securities claims against Acadia Healthcare to proceed after denying the defendants’ motion to dismiss. The ruling does not establish wrongdoing or liability, but continued litigation creates legal, financial, and reputational uncertainty. Acadia Healthcare Litigation Proceeds

Analyst Ratings Changes

ACHC has been the topic of a number of research analyst reports. Jefferies Financial Group upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and upped their target price for the stock from $24.50 to $30.00 in a research note on Wednesday, June 3rd. TD Cowen lifted their price target on shares of Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. Guggenheim boosted their price target on Acadia Healthcare from $26.00 to $31.00 and gave the company a “buy” rating in a report on Monday, May 4th. Royal Bank Of Canada raised their price objective on Acadia Healthcare from $28.00 to $31.00 and gave the stock an “outperform” rating in a report on Monday, May 4th. Finally, Raymond James Financial upgraded Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 target price for the company in a report on Monday, May 4th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $28.69.

Acadia Healthcare Price Performance

The company has a market cap of $3.01 billion, a PE ratio of -2.67, a price-to-earnings-growth ratio of 10.84 and a beta of 0.64. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 1.27. The firm has a 50 day simple moving average of $27.94 and a 200-day simple moving average of $23.50.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Tuesday, July 28th. The company reported $0.38 EPS for the quarter, beating the consensus estimate of $0.35 by $0.03. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The business had revenue of $865.84 million during the quarter, compared to analyst estimates of $844.19 million. During the same period in the prior year, the firm posted $0.83 earnings per share. The company’s quarterly revenue was down .4% on a year-over-year basis. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. As a group, research analysts predict that Acadia Healthcare Company, Inc. will post 1.5 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Acadia Healthcare

Several institutional investors have recently bought and sold shares of ACHC. EverSource Wealth Advisors LLC increased its position in shares of Acadia Healthcare by 54.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after purchasing an additional 497 shares in the last quarter. Wells Fargo & Company MN lifted its holdings in shares of Acadia Healthcare by 208.9% during the 4th quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock valued at $32,000 after purchasing an additional 1,510 shares during the last quarter. Bayforest Capital Ltd acquired a new stake in shares of Acadia Healthcare in the 4th quarter worth $52,000. GAMMA Investing LLC grew its stake in Acadia Healthcare by 124.7% during the 4th quarter. GAMMA Investing LLC now owns 4,862 shares of the company’s stock worth $69,000 after buying an additional 2,698 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd grew its stake in Acadia Healthcare by 4,264.8% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 5,325 shares of the company’s stock worth $76,000 after buying an additional 5,203 shares during the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.